Edelman Joseph's Form 4 filing
Verrica Pharmaceuticals Inc. (VRCA) · filed Dec 26, 2023
- Accession no.
- 0000899243-23-020691
- Filed
- Dec 26, 2023, 7:21 PM ET
- Trade date
- Dec 21-26, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $3.26M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Edelman JosephCIK 0001164426 | 10% Owner |
| Perceptive Advisors LLCCIK 0001224962 | 10% Owner |
| Perceptive Life Sciences Master Fund LtdCIK 0001249675 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 21, 2023 | Common Stock | PPurchaseAcquired | +200,000 | $6.17 | +$1,234,000 | 6,472,914 | Indirect | |
| Dec 22, 2023 | Common Stock | PPurchaseAcquired | +250,000 | $6.67 | +$1,667,500 | 6,722,914 | Indirect | |
| Dec 26, 2023 | Common Stock | PPurchaseAcquired | +54,652 | $6.49 | +$354,691.48 | 6,777,566 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.